Novorapid and hepatic steatosis Patient Reports February 12, 2012

Novorapid Side Effects Report #5752235-3
Novorapid side effect was reported by a Physician from TURKEY on May 19, 2008. Male patient, 45 years of age, weighting 172.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody, diabetes mellitus inadequate control, fatigue, hepatic steatosis, insulin resistance. Novorapid dosage: unknown. During the same period patient was treated with INSULATARDPENFILL. Patient recovered.

Novorapid Side Effects Report #5801359-0
Novorapid side effect was reported by a Physician from TURKEY on June 24, 2008. Male patient, 45 years of age, weighting 172.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody, diabetes mellitus inadequate control, fatigue, hepatic steatosis, insulin resistance. Novorapid dosage: unknown. During the same period patient was treated with INSULATARDPENFILL. Patient recovered.

Novorapid Side Effects Report #5834592-2
Novorapid side effect was reported by a Physician from TURKEY on July 28, 2008. Male patient, 45 years of age, weighting 172.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody, diabetes mellitus inadequate control, fatigue, hepatic steatosis, insulin resistance. Novorapid dosage: unknown. During the same period patient was treated with INSULATARDPENFILL. Patient recovered.

Novorapid Side Effects Report #5795860-6
Novorapid side effect was reported by a Physician from FRANCE on June 17, 2008. Female patient, 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic steatosis. Novorapid dosage: unknown. Patient recovered.


Novorapid Side Effects Report #5921022-5
Novorapid side effect was reported by a Physician from FRANCE on Oct 09, 2008. Female patient, 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic steatosis. Novorapid dosage: unknown. Patient recovered.

Novorapid Side Effects Report #5921024-9
Novorapid side effect was reported by a Physician from FRANCE on Oct 09, 2008. Female patient, 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic steatosis. Novorapid dosage: unknown. Patient recovered.

Novorapid Side Effects Report #5932326-4
Novorapid side effect was reported by a Physician from FRANCE on Oct 09, 2008. Female patient, 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic steatosis. Novorapid dosage: unknown. Patient recovered.

Novorapid Side Effects Report #5933504-0
Novorapid side effect was reported by a Physician from FRANCE on Oct 09, 2008. Female patient, 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic steatosis. Novorapid dosage: unknown. Patient recovered.

Novorapid Side Effects Report #5795861-8
Novorapid side effect was reported by a Physician from FRANCE on June 17, 2008. Female patient, 30 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic steatosis. Novorapid dosage: unknown. Patient recovered.


Novorapid Side Effects Report #4972849-8
Novorapid side effect was reported by a Physician from JAPAN on Sept 29, 2004. Female patient, 38 years of age, weighting 101.4 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: glycogen storage disease type viii, hepatic steatosis, liver function test abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, NOVOLIN N, NOVOLIN N, NOVORAPID CHU, PENFILL R CHU, PENFILL N CHU. Patient was hospitalized. Patient recovered.